Who invested in Akrevia Therapeutics?
Akrevia Therapeutics's investors include Atlas Venture and F-Prime Capital.
United States · Series A startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2018, from 1 source
Akrevia Therapeutics's investors include Atlas Venture and F-Prime Capital.
Akrevia Therapeutics has raised $30M across 1 round since 2018.
Akrevia Therapeutics's most recent round was a Series A of $30M in Sept 2018.
Its most recent round, $30M in Sept 2018, is also its largest on record.
Akrevia Therapeutics's first round on record, in Sept 2018, was backed by Atlas Venture and F-Prime Capital.
Akrevia Therapeutics's latest named round is a Series A, in Sept 2018.
Akrevia Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.